Health & Personal Care
HIGH
FDA DRUG
Bristol-Myers Squibb Opdualag Vial Recall for Sterility Risk: 12,778 Units (2025)
Bristol-Myers Squibb recalled 12,778 Opdualag single-dose vials nationwide after a lack of assurance of sterility was identified. The product is nivolumab and relatlimab-rmbw injection. The recall date is 2025-10-21. Healthcare providers should stop using affected lots and follow the recall letter guidance.
Opdualag
Lack of